[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572100":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":35,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"First Affiliated Hospital of Zhejiang University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision",null,"No additional intervention is imposed on patients except normal clinical diagnosis and treatment.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Tao Wang, Ph.d","CONTACT","+86-197-068-25286","15002740874@163.com",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine","RECRUITING","Hangzhou","Zhejiang","310000","China","CN",{"type":28,"coordinates":29},"Point",[30,31],120.16142,30.29365,{"lat":31,"lon":30},[34],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Jichao Qin","Professor","100572100","analysis-of-lymph-node-metastasis-and-tumor-deposit-in-the-short-gastric-mesentery-following-total-gastrectomy-for-gastric-cancer-100572100",false,"NCT06728878","Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer","Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy With D2 Lymphadenectomy Plus Complete Mesogastric Excision for Gastric Cancer: A Prospective Observational Study","zytg001","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years\n2. Primary gastric adenocarcinoma confirmed by preoperative pathology result\n3. cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition\n4. Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision\n5. American Society of Anesthesiologists (ASA) class I, II, or III\n6. Written informed consent\n\nExclusion Criteria:\n\n1. Negative preoperative biopsy\n2. Too late tumour stage or metastasis (cT4b\u002FM1)\n3. BMI\\>30 kg\u002Fm2\n4. previous neoadjuvant chemotherapy or radiotherapy\n5. Previous upper abdominal surgery\n6. Combined with other malignant diseases\n7. Reject operation","ALL","18 Years","85 Years",{"count":51,"type":52},150,"ESTIMATED","3 Years","OBSERVATIONAL","This study aims to explore lymph node metastasis in the short gastric mesentery following total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision, providing evidence-based medicine for standardizing lymph node dissection in gastric cancer.",[57],"Gastric Cancers",[59,60,61,62,63],"Gastric cancer","Lymph node dissection","Short gastric mesentery","Lymph node metastasis","Tumor location","2025-08-25",{"date":66,"type":67},"2025-09-02","ACTUAL",{"date":69,"type":67},"2024-05-01",{"date":71,"type":52},"2027-12-31",{"name":37,"class":6},1]